Overview

An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical Practice

Status:
Completed
Trial end date:
2017-10-23
Target enrollment:
Participant gender:
Summary
This observational trial will evaluate the effectiveness, the consistency of evaluation scores, quality of life, safety and tolerability of TCZ administered subcutaneously (SC) in participants with RA in daily clinical practice.
Details
Lead Sponsor:
Hoffmann-La Roche
Collaborator:
nv Roche sa